{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:07:11Z","timestamp":1790276831017,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["DST\/INT\/Iran\/p-05\/2018"],"award-info":[{"award-number":["DST\/INT\/Iran\/p-05\/2018"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["R.1103\/44\/2021-GIA\/HR"],"award-info":[{"award-number":["R.1103\/44\/2021-GIA\/HR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.humimm.2025.111328","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T15:41:40Z","timestamp":1747496500000},"page":"111328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expression variation of Akt and cytokines in lamivudine-resistant HBV rare mutation that prematurely truncates the overlapping surface protein"],"prefix":"10.1016","volume":"86","author":[{"given":"Saniya","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayesh Kumar","family":"Sevak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaneez","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahvish","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum","family":"Jehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupama","family":"Trehanpati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Naqui","family":"Kazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2025.111328_b0005","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.humimm.2025.111328_b0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.20517\/2394-5079.2016.05","article-title":"Hepatitis B virus molecular biology and pathogenesis","volume":"2","author":"Lamontagne","year":"2016","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.humimm.2025.111328_b0015","doi-asserted-by":"crossref","unstructured":"S. Khan, A. Anwer, J.K. Sevak, N. Trehanpati, S.N. Kazim. Cytokines expression compared to the determinants of cellular apoptosis prominently attributes to the deleterious effects of \u2018A\u2019 determinant surface gene mutations in HBV transfected hepatoma cell line. Immunol. Invest., Taylor & Francis (2024) 224\u2013240. Doi: 10.1080\/08820139.2023.2288841.","DOI":"10.1080\/08820139.2023.2288841"},{"key":"10.1016\/j.humimm.2025.111328_b0020","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1073\/pnas.88.19.8495","article-title":"Inhibition of the replication of hepatitis B virus in vitro by 2\u2019,3\u2019-dideoxy-3\u2019-thiacytidine and related analogues","volume":"88","author":"Doong","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humimm.2025.111328_b0025","first-page":"1657","article-title":"Preliminary trial of lamivudine for chronic hepatitis B infection","volume":"333","author":"Ules","year":"1990","journal-title":"Massachusetts Med. Soc."},{"key":"10.1016\/j.humimm.2025.111328_b0030","doi-asserted-by":"crossref","unstructured":"Lai, Ching Lung, Chi Kong Ching, Angus Kwong Ming Tung, Eileen Li, John Young, Andrew Hill, Benjamin Chun Yu Wong, Julie Dent, and Pui Chee Wu. 1997. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial. Hepatology. John Wiley and Sons Inc.: 241\u2013244. Doi: 10.1002\/hep.510250144.","DOI":"10.1002\/hep.510250144"},{"key":"10.1016\/j.humimm.2025.111328_b0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1517\/14656566.3.3.329","article-title":"Lamivudine for the treatment of chronic hepatitis B","volume":"3","author":"Sokal","year":"2002","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.humimm.2025.111328_b0040","doi-asserted-by":"crossref","unstructured":"Y.F. Liaw, Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B. J. Gastroenterol. Hepatol. (Australia) 17 (2002) Blackwell Publishing. Doi: 10.1046\/J.1440-1746.17.S3.23.X.","DOI":"10.1046\/j.1440-1746.17.s3.23.x"},{"key":"10.1016\/j.humimm.2025.111328_b0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jmv.23530","article-title":"High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates","volume":"85","author":"Neumann-Fraune","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.humimm.2025.111328_b0050","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jhep.2012.01.005","article-title":"Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants","volume":"56","author":"Billioud","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.humimm.2025.111328_b0055","doi-asserted-by":"crossref","unstructured":"The 22nd Conference of the Asian Pacific Association for the Study of the Liver\u00a0: APASL 2012 - Taipei, Taiwan - 16-19 February. 2012. Hepatology international 6. Hepatol Int: 44\u201366. Doi: 10.1007\/S12072-011-9332-5.","DOI":"10.1007\/s12072-011-9332-5"},{"key":"10.1016\/j.humimm.2025.111328_b0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.22295","article-title":"The antiviral drug selected hepatitis B virus rtA181T\/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound","volume":"48","author":"Warner","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2025.111328_b0065","unstructured":"Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant - PubMed. 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/18572757\/. Accessed February 5."},{"key":"10.1016\/j.humimm.2025.111328_b0070","doi-asserted-by":"crossref","unstructured":"J. Torresi, , Linda Earnest-Silveira, Georgia Deliyannis, Kristy Edgtton, Hui Zhuang, Stephen A. Locarnini, Janet Fyfe, Tina Sozzi, David C. Jackson, Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293 (2002) 305\u2013313. Doi: 10.1006\/viro.2001.1246.","DOI":"10.1006\/viro.2001.1246"},{"key":"10.1016\/j.humimm.2025.111328_b0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-kappaB: linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2025.111328_b0080","doi-asserted-by":"crossref","unstructured":"H. Wang, Heng Luo, Xing Wan, Xiaolan Fu, Qing Mao, Xiaomei Xiang, Yi Zhou, et al. TNF-\u03b1\/IFN-\u03b3 profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection. J. Hepatol. 72 (2020) 45\u201356. Doi: 10.1016\/J.JHEP.2019.08.024.","DOI":"10.1016\/j.jhep.2019.08.024"},{"key":"10.1016\/j.humimm.2025.111328_b0085","doi-asserted-by":"crossref","unstructured":"H.L. Weng, Bao En Wang, Ji Dong Jia, Wan Fen Wu, Jian Zhong Xian, Peter R. Mertens, Wei Min Cai, Steven Dooley, Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. Clin. Gastroenterol. Hepatol., (2005) 819\u2013828. Doi: 10.1016\/S1542-3565(05)00404-0.","DOI":"10.1016\/S1542-3565(05)00404-0"},{"key":"10.1016\/j.humimm.2025.111328_b0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/annonc\/mdm448","article-title":"Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma","volume":"19","author":"Porta","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.humimm.2025.111328_b0095","doi-asserted-by":"crossref","unstructured":"C. Zhou, Ning Zhang, Ting Ting He, Yao Wang, Li Fu Wang, Yong Qiang Sun, Jing Jing, et al. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure. World J. Gastroenterol., 26 (2020) 4479\u20134488. Doi: 10.3748\/WJG.V26.I30.4479.","DOI":"10.3748\/wjg.v26.i30.4479"},{"key":"10.1016\/j.humimm.2025.111328_b0100","doi-asserted-by":"crossref","unstructured":"K. Xiang, Bin Wang, Role of the PI3K\u2013AKT\u2013mTOR pathway in hepatitis B virus infection and replication, Mol. Med. Rep. 17 (2018) 4713\u20134719. Doi: 10.3892\/MMR.2018.8395.","DOI":"10.3892\/mmr.2018.8395"},{"key":"10.1016\/j.humimm.2025.111328_b0105","doi-asserted-by":"crossref","unstructured":"S. Rawat, Michael J. Bouchard, The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. J. Virol. 89 (2015) 999\u20131012. Doi: 10.1128\/JVI.02440-14.","DOI":"10.1128\/JVI.02440-14"},{"key":"10.1016\/j.humimm.2025.111328_b0110","doi-asserted-by":"crossref","unstructured":"Liu, Wei, Teng Fei Guo, Zhen Tang Jing, Zhi Yang, Lei Liu, Yuan Ping Yang, Xu Lin, Qiao Yun Tong. 2018. Hepatitis B virus core protein promotes hepatocarcinogenesis by enhancing Src expression and activating the Src\/PI3K\/Akt pathway. FASEB journal\u00a0: official publication of the Federation of American Societies for Experimental Biology 32. FASEB J: 3033\u20133046. Doi: 10.1096\/FJ.201701144R.","DOI":"10.1096\/fj.201701144R"},{"key":"10.1016\/j.humimm.2025.111328_b0115","doi-asserted-by":"crossref","unstructured":"H. Liu, Jiejie Xu, Lei Zhou, Xiaojing Yun, Lin Chen, Shanshan Wang, Linlin Sun, Yumei Wen, and Jianxin Gu, Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src\/PI3K\/Akt pathway, Cancer Res. 71 (2011) 7547\u20137557. Doi: 10.1158\/0008-5472.CAN-11-2260.","DOI":"10.1158\/0008-5472.CAN-11-2260"},{"key":"10.1016\/j.humimm.2025.111328_b0120","doi-asserted-by":"crossref","unstructured":"Z.-T. Jing, Wei Liu, Shu-Xiang Wu, Yun He, Yan-Ting Lin, Wan-Nan Chen, Xin-Jian Lin, Xu Lin, Hepatitis B virus surface antigen enhances the sensitivity of hepatocytes to Fas-mediated apoptosis via suppression of AKT phosphorylation. J. Immunol., 201 (2018) 2303\u20132314. Doi: 10.4049\/JIMMUNOL.1800732.","DOI":"10.4049\/jimmunol.1800732"},{"key":"10.1016\/j.humimm.2025.111328_b0125","doi-asserted-by":"crossref","unstructured":"S.N. Kazim, Shiv Kumar Sarin, Barjesh Chander Sharma, Luqman Ahmad Khan, and Seyed Ehtesham Hasnain, Characterization of naturally occurring and lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India. Intervirology 49 (2006) 152\u2013160. Doi: 10.1159\/000089376.","DOI":"10.1159\/000089376"},{"key":"10.1016\/j.humimm.2025.111328_b0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif.)"},{"key":"10.1016\/j.humimm.2025.111328_b0135","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1499-3872(16)60064-4","article-title":"Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis","volume":"15","author":"Wang","year":"2016","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.humimm.2025.111328_b0140","doi-asserted-by":"crossref","unstructured":"X. Zhou, Fan Yang, Ying Yang, Ying Hu, Weixia Liu, Chunhong Huang, Shuping Li, Zhi Chen, HBV facilitated hepatocellular carcinoma cells proliferation by up-regulating angiogenin expression through IL-6, Cell Physiol. Biochem. 46 (2018) 461\u2013470. Doi: 10.1159\/000488614.","DOI":"10.1159\/000488614"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925000990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925000990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:15:47Z","timestamp":1759400147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925000990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0198885925000990"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111328","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression variation of Akt and cytokines in lamivudine-resistant HBV rare mutation that prematurely truncates the overlapping surface protein","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111328"}}